The world has just surpassed the barrier of one hundred million confirmed cases of COVID-19, with Europe crying out to heaven for the insufficient supply of vaccines by pharmaceutical companies. An increasingly angry Brussels is now threatening to verify the exports of vaccine producers on the suspicion that they are selling the vaccines promised to Europe to third parties.
Sanofi to produce 100 million doses of Pfizer for Europe
In this context, the French Sanofi, which has been unable to develop its own vaccine, has offered its factory in Frankfurt to produce those of its competitors and thus feed the European market, which it says it will supply one hundred million doses of Pfizer BioNTech starting next August.
But in the meantime, the problem persists, with Pfizer and AstraZeneca unable to keep up and deliver the promised vaccines to Europe on time.
“Vaccination is becoming a real problem -denounced this Tuesday Markus Söder, minister-president of Bavaria-. They simply lack vaccines. The process is much slower than it should be and it is becoming a psychological burden. “
Distrust settles between the EU and pharmaceutical companies
Distrust has settled between the European Union and pharmaceutical companies. Brussels even threatens to control its exports, to verify that they are not selling the promised doses to third parties.
“The word here is transparency says Eric Mamer, spokesman for the European Commission. It is not about blocking. It is about knowing what companies are exporting or are going to export to markets outside the European Union“.
UK Says “Protectionism” of Vaccines “Not the Right Approach”
The United Kingdom, which already has 100,000 deaths from coronavirus, calls for calm and unity in the face of the pandemic.
“I urge all international partners to collaborate and work closely. I believe that protectionism is not the right approach in the midst of a pandemic.”said Matt Hancock, Britain’s health minister.
A Spanish antiviral emerges as the most powerful drug against COVID-19
The good news comes from a Spanish antiviral, plitidepsin. Laboratory tests, carried out on animals, have shown a 99% decrease in the viral load of SARS-Cov-2.
In the absence of confirming clinical tests, the drug, manufactured by the Spanish Pharmamar and used so far as an antitumor, appears to be the most potent compound discovered so far against COVID-19.